Revenue ($USD) : $1,058,522,000
R&D spend : $84,423,000
Employees : 4,200
Fiscal year end : 12/31/2023
CEO : Adam Elsesser

www.penumbrainc.com

Penumbra was founded in 2004 by President, Chair and CEO Adam Elsesser and Dr. Arani Bose, who formerly served as chair, chief medical officer and chief innovator. Penumbra develops interventional devices for vascular and neuro therapies, including catheters, coils and clot retrievers. In 2024, Penumbra launched its Lightning Flash 2.0 computer-assisted vacuum thrombectomy (CAVT) system in the U.S. and its BMX81 and BMX96 neuro access catheters in Europe. –JH

MORE ON MDO: How Penumbra’s smart-sucking algorithms and catheters speed up clot removal